CompanyGraph
What stands out
- Returns appear driven by leverage
At a glance
- Depends onDownstream position: depends on 12 industries, supplies 7
- ScaleMarket cap is $2.11B, above the global median of $1.15B
- PositionReturn on equity is 368%, higher than 95% of its Medical Care Facilities peers (median 11.6%)
- Interpretations8 currently firing — 8
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
What stands out
- Returns appear driven by leverage
Financials view
Market Capitalization
2.11BUSDvs all stocks (USD)
Trailing P/E
8.21xvs Medical Care Facilities peers
Revenue (TTM)
2.52BUSDvs all stocks (USD)
Profit Margin
10.37%vs Medical Care Facilities peers
Beta
1.89xvs all stocks
52-Week Change
140.45%vs all stocks
Market Capitalization
2.11BUSDvs all stocks (USD)
Enterprise Value
3.42BUSDvs all stocks (USD)
Trailing P/E
8.21xvs Medical Care Facilities peers
Forward P/E
12.48xvs Medical Care Facilities peers
PEG Ratio
0.0154xvs Medical Care Facilities peers
Price to Sales (TTM)
0.8367xvs Medical Care Facilities peers
Price to Book (MRQ)
8.75xvs Medical Care Facilities peers
Enterprise to Revenue
1.35xvs Medical Care Facilities peers
Enterprise to EBITDA
11.01xvs Medical Care Facilities peers
Gross Margin
31.71%vs Medical Care Facilities peers
Profit Margin
10.37%vs Medical Care Facilities peers
Operating Margin
11.18%vs Medical Care Facilities peers
Return on Assets (TTM)
10.17%vs Medical Care Facilities peers
Return on Equity (TTM)
368.01%vs Medical Care Facilities peers
Revenue (TTM)
2.52BUSDvs all stocks (USD)
Revenue per Share (TTM)
12.10USDUpdated Jul 18, 2026Quarterly Revenue Growth
15.90%vs Medical Care Facilities peers
Gross Profit (TTM)
826.15MUSDvs all stocks (USD)
EBITDA (TTM)
312.06MUSDvs all stocks (USD)
Net Income (TTM)
261.49MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
702.10%vs Medical Care Facilities peers
Operating Cash Flow (TTM)
138.84MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
82.58MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 18, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Care Facilities peers
Revenue
2.43BUSDFY2025 · Dec 31, 2025Cost of Goods Sold
1.62BUSDFY2025 · Dec 31, 2025Gross Profit
810.48MUSDFY2025 · Dec 31, 2025Operating Income
260.28MUSDvs all stocks (USD)
Pre-tax Income
106.95MUSDFY2025 · Dec 31, 2025Income Tax Expense
-118.09MUSDFY2025 · Dec 31, 2025Net Income
225.03MUSDFY2025 · Dec 31, 2025EBIT
241.18MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
285.52MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
528.80MUSDFY2025 · Dec 31, 2025Other Operating Expenses
10.87MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
2.83MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
134.23MUSDFY2025 · Dec 31, 2025Net Income from Continuing Operations
225.03MUSDFY2025 · Dec 31, 2025Operating Cash Flow
66.35MUSDFY2025 · Dec 31, 2025Free Cash Flow
58.90MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
193.26MUSDFY2025 · Dec 31, 2025Income Tax Paid
30.77MUSDFY2025 · Dec 31, 2025Interest Paid
143.10MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
225.03MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
28.22MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
-143.03MUSDFY2025 · Dec 31, 2025Stock-based Compensation
25.06MUSDFY2025 · Dec 31, 2025Other Non-cash Items
5.85MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-30.22MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
-6.23MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-38.34MUSDFY2025 · Dec 31, 2025Capital Expenditures
-7.45MUSDFY2025 · Dec 31, 2025Net Acquisitions
-14.85MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-22.30MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
1.32BUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-1.32BUSDFY2025 · Dec 31, 2025Net Short-term Debt Issuance
-3.75MUSDFY2025 · Dec 31, 2025Other Financing Charges
2.65MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-4.86MUSDFY2025 · Dec 31, 2025Shares Outstanding
217.51MSharesUpdated Jul 18, 2026Float Shares
86.95MSharesUpdated Jul 18, 2026Shares Short
3.86MSharesUpdated Jul 18, 2026Short Ratio
1.67daysvs all stocks
Short % of Shares Outstanding
4.33%vs all stocks
% Held by Insiders
5.80%vs all stocks
% Held by Institutions
91.95%vs all stocks
Total Cash (MRQ)
197.27MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
0.9060USDUpdated Jul 18, 2026Total Debt (MRQ)
1.50BUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
6.24xvs Medical Care Facilities peers
Current Ratio (MRQ)
1.47xvs Medical Care Facilities peers
Book Value per Share (MRQ)
1.11USDUpdated Jul 18, 2026Total Assets
2.01BUSDvs all stocks (USD)
Total Current Assets
560.23MUSDFY2025 · Dec 31, 2025Total Liabilities
1.82BUSDFY2025 · Dec 31, 2025Total Non-current Assets
1.45BUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
1.39BUSDFY2025 · Dec 31, 2025Total Current Liabilities
424.46MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
193.26MUSDFY2025 · Dec 31, 2025Accounts Receivable
316.12MUSDFY2025 · Dec 31, 2025Accounts Payable
31.97MUSDFY2025 · Dec 31, 2025Short-term Debt
200.44MUSDFY2025 · Dec 31, 2025Other Current Liabilities
9.81MUSDFY2025 · Dec 31, 2025Long-term Debt
1.31BUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
800.00KUSDFY2025 · Dec 31, 2025Common Stock (Book)
2.11MUSDFY2025 · Dec 31, 2025Retained Earnings
-1.16BUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
195.19MUSDvs all stocks (USD)
52-Week Low
3.73USDUpdated Jul 18, 202652-Week High
10.32USDUpdated Jul 18, 202652-Week Change
140.45%vs all stocks
Beta
1.89xvs all stocks
50-Day MA
7.88USDUpdated Jul 18, 2026200-Day MA
8.05USDUpdated Jul 18, 2026Avg 10-Day Volume
2.32MSharesUpdated Jul 18, 2026Avg 30-Day Volume
2.27MSharesUpdated Jul 18, 2026Diluted EPS (TTM)
1.18USDUpdated Jul 18, 2026Other Income / Expense
-16.07MUSDFY2025 · Dec 31, 20258 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Diagnostic
Elevated ROE With High Debt-to-Equity and Equity Multiplier
Return on equity reads high on a balance sheet carrying a lot of debt against that equity.
Reads
Diagnostic
Rising Operating Income With Low Depreciation on a Capital-Heavy Balance Sheet
Operating income rose four years, with small depreciation on a capital-heavy balance sheet.
Reads
Industry-Benchmarked Return on Capital Elevated
It earns more on its assets and its equity than its industry, and gets more sales from those assets.
Reads
Low Fixed-Asset Share With Elevated Turnover
It owns few buildings and machines, yet gets more sales and profit from its assets than its industry does.
Reads
Minimal Tax and Interest Drag
Almost nothing is lost between its operating profit and its net income.
Reads
Where is this company structurally exposed?
Within or Near the Altman Distress Zone
Debt is a large share of its assets, and large against its cash flow.
Reads
Elevated Leverage on Three Denominators
Debt sits high against its equity, its assets, and its cash flow.
Reads
Receivables Heavy and Growing
Money owed by customers keeps growing, and is much of its current assets.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Return on equity is 368%, higher than 95% of its Medical Care Facilities peers (median 11.6%)Significant
Return on equity: 3.68Industry median: 0.12Industry P95: 0.67Peers compared: 32.00
P/E ratio is 8.21×, lower than 95% of its Medical Care Facilities peers (median 26.1×)Notable
P/E ratio: 8.21Industry median: 26.10Industry P5: 8.86Peers compared: 32.00
Structural Tensions
Returns appear driven by leverageSignificant
Return on Equity: 3.68Debt-to-Equity: 6.24
Financial Health
Altman Z-Score 1.58: grey zoneSignificant
Altman Z-Score: 1.58
Supply Chain
Downstream position: depends on 12 industries, supplies 7Notable
Outgoing: 7.00Incoming: 12.00
High connectivity hub: 19 industry connectionsNotable
Total Connections: 19.00
Scale
Market cap is $2.11B, above the global median of $1.15BNotable
Market cap (USD): 2,110,047,917Global Median: 1,146,734,693.424
Revenue is $2.52B, above the global median of $520.53MNotable
Revenue (USD): 2,521,890,048Global Median: 520,528,949.311
Levered free cash flow is $82.58M, above the global median of $16.24MNotable
Levered free cash flow (USD): 82,576,248Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Okeanis Eco Tankers Corp
Tier 1FlowThroughput-Bound ConversionRiskProduction
China Meheco Co., Ltd.
Tier 1FlowThroughput-Bound ConversionProductionRisk
Wisdom Marine Lines Co., Ltd.
Tier 1FlowThroughput-Bound ConversionProductionRisk
Höegh Autoliners ASA
Tier 1FlowThroughput-Bound ConversionProductionRisk
Hanmi Science Co., Ltd.
Tier 1FlowThroughput-Bound ConversionProductionRisk
Sovcomflot OAO
Tier 1FlowThroughput-Bound ConversionRiskProduction
OEM International AB
Tier 1FlowThroughput-Bound ConversionInterfaceProduction
BW LPG Limited
Tier 1FlowThroughput-Bound ConversionProductionRisk
Qingdao Baheal Pharmaceutical Co. Ltd.
Tier 1FlowThroughput-Bound ConversionProductionRisk
Kiler Holding A.S.
Tier 1FlowThroughput-Bound ConversionProductionInterface
Companies that share active interpretations — structural patterns currently present in both stocks.
The Sherwin-Williams Company
4 interpretationsRising Operating Income With Low Depreciation on a Capital-Heavy Balance SheetElevated Leverage on Three DenominatorsElevated ROE With High Debt-to-Equity and Equity MultiplierIndustry-Benchmarked Return on Capital Elevated
Cencora Inc.
5 interpretationsElevated Leverage on Three DenominatorsReceivables Heavy and GrowingElevated ROE With High Debt-to-Equity and Equity MultiplierIndustry-Benchmarked Return on Capital ElevatedLow Fixed-Asset Share With Elevated Turnover
Travere Therapeutics Inc.
4 interpretationsElevated Leverage on Three DenominatorsElevated ROE With High Debt-to-Equity and Equity MultiplierIndustry-Benchmarked Return on Capital ElevatedLow Fixed-Asset Share With Elevated Turnover